Pharmacological Correlation between Total Drug Concentration and Lactones of CPT-11 and SN-38 in Patients Treated with CPT-11
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-01-31
著者
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
OHTSU Tomoko
Amgen Limited
-
OHTSU Tomoko
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
FUJII Hirofumi
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
IGARASHI Tadahiko
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
SASAKI Yasutsuna
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
Itoh K
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Igarashi T
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Igarashi Tadahiko
神戸大学 医学研究科腫瘍内科学
-
Igarashi Tadahiko
国立がんセンター東病院
-
Igarashi Tadahiko
Division Of Hematology And Oncology National Cancer Center Hospital East
-
Ichimura Koichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Ishizawa Kenichi
東北大学 血液･免疫病学分野
-
Ishizawa Kenichi
国立がんセンター東病院
-
WAKITA Hisashi
Division of Hematology and Oncology, Japanese Red Cross Narita Hospital
-
Itoh Kuniaki
Division Of Oncology And Hematology National Cancer Center Hospital East
-
YOSHIDA Yasushi
Developmental Research Laboratories, Daiichi Pharmaceutical Co., Ltd
-
SUDOH Kenichi
Developmental Research Laboratories, Daiichi Pharmaceutical Co., Ltd
-
HAKUSUI Hideo
Developmental Research Laboratories, Daiichi Pharmaceutical Co., Ltd
-
Sudoh Kenichi
Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd
-
Fujii H
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Ohtsu Tomoko
Amgen Kk
-
Sasaki Yasutsuna
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Ichimura Koichi
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Fujii Hirofumi
Division Of Hematology/oncology Beth Israel Deaconess Medical Center
-
Fujii Hideji
Research Laboratories Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Wakita Hisashi
Division Of Hematology And Oncology National Cancer Center Hospital East
-
Wakita Hisashi
Division Of Hematology And Oncology Japanese Red Cross Narita Hospital
-
Ohtsu Tomoko
Division Of Oncology/hematology National Cancer Center Hospital East
-
Itoh Kuniaki
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Hakusui Hideo
Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd
-
Hakusui Hideo
Development Research Laboratories Daiichi Pharmaceutical Co. Ltd
-
Sasaki Yasutsuna
Division Of Hematology And Oncology National Cancer Center Hospital East
-
Yoshida Yasushi
Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd
-
Takahashi Isao
Second Department Of Internal Medicine Okayama University Medical School
-
Itoh Kuniaki
Division of Hematology and Oncology, National Cancer Center Hospital East
-
Ohtsu Tomoko
Division of Hematology and Oncology, National Cancer Center Hospital East
関連論文
- Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Clonal Analysis of Bilateral, Recurrent, or Systemically Multifocal Ocular Adnexal Lymphoma
- Different Kinetics of WT1 and PML-RARα Gene Expression Levels during Remission Induction Therapy with All-trans Retinoic Acid Alone in Acute Promyelocytic Leukemia
- Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
- Lethal Adenovirus Infection in a Patient Who Had Undergone Nonmyeloblative Stem Cell Transplantation
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases
- Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
- Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
- Acquired hemophilia A with sigmoid colon cancer : successful treatment with rituximab followed by sigmoidectomy
- A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma : β2-microglobulin associated with time to progression
- Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
- Increased Expression of Insulin-Like Growth Factor I is Associated with Ara-C Resistance in Leukemia
- Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
- Detection of Clone-Specific Immunoglobulin Heavy Chain Genes in the Bone Marrow of B-cell-Lineage Lymphoma after Treatment
- High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
- Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation : participation of host immune cells
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Case-control study of leukemia and diagnostic radiation exposure
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Correlation Between Histological Evaluation and PCR-based Clonality Analysis of Gastric MALT Lymphomas Treated by Eradication of Helicobacter pylori
- Follicular lymphoma frequently originates in the salivary gland
- p27^ is Detected on Most Gastric MALT Lymphomas, but not Large Cell Lymphomas
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Pregnancy-Associated Cytotoxic Lymphoma: A Report of 4 Cases
- Peripheral T/Natural Killer - Cell Lymphoma Involving the Female Genital Tract: A Clinicopathologic Study of 5 Cases
- A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
- Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice
- Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
- Extragonadal germ cell tumors in Japan
- Treatable Subsets in Cancer of Unknown Primary Origin
- Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
- Recurrent Breast Cancer Treated Successfully with Mitomycin-C and Vinblastine after Failure of Both Doxorubicin-containing Regimen and Paclitaxel : A Case Report
- A Limited Sampling Model for Estimating Pharmacokinetics of CPT-11 and Its Metabolite SN-38
- Pharmacological Correlation between Total Drug Concentration and Lactones of CPT-11 and SN-38 in Patients Treated with CPT-11
- Atypical Lymphoplasmacytic and Immunoblastic Proliferation of Autoimmune Disease : Clinicopathologic and Immunohistochemical Study of 9 Cases
- Unmanipulated Reduced-Intensity Stem Cell Transplantation from a Haploidentical Donor Mismatched at 3 HLA Antigens to a Patient with Leukemic Transformation of Myelodysplastic Syndrome : Successful Second Transplantation after Graft Rejection
- Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
- High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
- Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
- Different Histopathological Types of Orbital Lymphoma 16 Years after Systemic Follicular Lymphoma : Immunohistochemical and Immunogenetic Analyses of Two Cases
- Microbial Serine Carboxypeptidase Inhibitors : Comparative Analysis of Actions on Homologous Enzymes Derived from Man, Yeast and Wheat
- Stereoscopic Scintigraphic Imaging of Breast Cancer Sentinel Lymph Nodes
- Patients with localized primary non-tonsillar oral diffuse large B-cell lymphoma exhibit favorable prognosis despite a non-germinal center B-cell-like phenotype
- Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
- Clinical, biochemical, and cytochemical studies on a Japanese Salla disease case associated with a renal disorder
- What is the most informative pharmacodynamic model for paclitaxel (T)? : a 3 hour-infusion vs. 24-hour infusion.
- Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
- WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
- Suicide Gene Therapy for Chemically Induced Rat Bladder Tumor Entailing Instillation of Adenoviral Vectors
- Photo-Induced Reactions of Oxime O-Ethers Derived from 3-Acyl-1, 2-dihydrocinnoline- 1, 2-dicarboximides
- Novel Photo-Rearrangement of Oxime Methyl Ethers of 3-Acyl-1, 2dihydrocinnoline-N-phenyl-1, 2-dicarboximides
- Phase I Study of Paclitaxel by Three-hour Infusion : Hypotension Just after Infusion Is One of the Major Dose-limiting Toxicities
- Oblique view of preoperative lymphoscintigraphy improves detection of sentinel lymph nodes in esophageal cancer
- In situ Gene Transfer and Suicide Gene Therapy of Gastric Cancer Induced by N-Ethyl-N'-nitro-N-nitrosoguanidine in Dogs
- Positron Emission Tomography/Computed Tomography after Immunocytochemical and Clonal Diagnosis of Intraocular Lymphoma with Vitrectomy Cell Blocks
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma
- A Pharmacokinetic and Pharmacodynamic Analysis of CPT-11 and Its Active Metabolite SN-38
- Frequent downregulation or loss of CD79a expression in plasma cell myelomas : Potential clue for diagnosis
- Correlation Between Histological Evaluation and PCR-based Clonality Analysis of Gastric MALT Lymphomas Treated by Eradication of Helicobacter pylori
- Immunoglobulin G4 (IgG4)-Positive or -Negative Ocular Adnexal Benign Lymphoid Lesions in Relation to Systemic Involvement
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Atypical Lymphoplasmacytic and Immunoblastic Proliferation of Autoimmune Disease : Clinicopathologic and Immunohistochemical Study of 9 Cases
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- BAFF-R is Expressed on B-cell Lymphomas Depending on their Origin, and its Related to Proliferation Index of Nodal Diffuse Large B-cell Lymphomas
- Review of primary unknown cancer : cases referred to the National Cancer Center Hospital East
- Comparison of Long-Term Clinical Outcomes of CHOP Chemotherapy between Japanese Patients with Nodal Peripheral T-Cell Lymphomas and Those with Diffuse Large B-Cell Lymphoma in the Study Group of the Tohoku Hematology Forum
- Bilateral Conjunctival Lesions in Blastic Plasmacytoid Dendritic Cell Neoplasm
- Clinicopathological Features of Malignant Lymphoma in Japan : The Miyagi Study
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene
- Neurotoxins, 1-methy1-4-phenyl-1, 2, 3, 6-tetrahydropyridine, 1, 2, 3, 4, -tetrahydroisoquinoline, N-methyl-tetrahydroisoquinoline and 1-benzyl-tetrahydroisoquinoline, are substrates for rat liver flavin-containing monooxygenase(FMO) expressed in yeast
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- Local Recurrence as Immunoglobulin G4 (IgG4)-Related Disease 10 Years after Radiotherapy to Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue
- Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria
- Diagnosis of Intestinal Graft-versus-Host Disease and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation
- Orbital MALT Lymphoma, Abdominal Hodgkin lymphoma, and Systemic Diffuse Large B-cell Lymphoma Develop Sequentially in One Patient
- Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95